Home   |   Research & Knowledge   |   Contact   |   Careers   |   FAQs
Gainers & Losers
Weekly Gainers
Weekly Losers
New Highs & New Lows
52 Week Highs
52 Week Lows
Advance and Decline
Bulk Deals
Block Deals
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Prices
Company News
Directors Reports
Share Holding Pattern
Quoted & Unquoted Investment
Equity History
Foreign Market
Pre Session
Mid Session
End Session
FII Activities
MF Activities
 
Kabra Drugs Ltd
Pharmaceuticals - Indian - Formulations
Market Cap : 0   Equity & F.V : 4.39 | 10   Group : Indian Private
Latest Reserves : -4.4   Book Value : -0.0328018   52 Week H/L : 1.12 | 0.52
Latest Debt : 0.67   PE & EPS : 0.00 | 0   Div Yield : 0.00
Last Traded Price
0.98
 
Open
0.98
 
Today's Change
0.04 (4.26%)
 
Prev. Day's Close
0.94
 
Volume
1001
Chart
 
  BSE
 Net Change 0.04
 Best Buy -/-
 Best Sell -/-
 Best Quantity
 Sell Quantity
 Today's Range 0.98 - 0.98
 52-Week High 1.12
 52-Week Low 0.52
Latest News On
01 Jan,2020
Kabra Drugs Ltd - Statement Of Investor Complaints For The Quarter Ended December 2019
13 Dec,2019
Kabra Drugs Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
10 Dec,2019
Kabra Drugs Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
10 Dec,2019
Kabra Drugs Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
07 Dec,2019
Kabra Drugs Ltd - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
More Headlines
 
Related Articles
No Data Found..!
   
Back Top
Home   |   The Company   |   Portfolio Management   |   Research & Knowledge   |   Privacy & Security
© 2011, Equity Intelligence Pvt. Ltd.       Developed & powered by CMOTS Infotech (ISO 9001:2015 certified)